Title  | Date  | Price  |
|---|
Idenix Pharmaceuticals Inc-Detailed Product Pipeline
| Sep 2009 |
£455 |
iBioPharma, Inc.-Detailed Product Pipeline
| Sep 2009 |
£455 |
HUYA Bioscience International, LLC-Company Report
| Sep 2009 |
£455 |
Idera Pharmaceuticals Inc-Detailed Product Pipeline
| Sep 2009 |
£455 |
IntelGenx Technologies Corp.-Detailed Product Pipeline
| Sep 2009 |
£455 |
Helix BioMedix Inc-Detailed Product Pipeline
| Sep 2009 |
£455 |
Imagenetix Inc-Detailed Product Pipeline
| Sep 2009 |
£455 |
Hemobiotech Inc-Detailed Product Pipeline
| Sep 2009 |
£455 |
Hologic Inc-Detailed Product Pipeline
| Sep 2009 |
£455 |
Hana Biosciences Inc-Detailed Product Pipeline
| Sep 2009 |
£455 |
Hospira Inc-Detailed Product Pipeline
| Sep 2009 |
£455 |
Interleukin Genetics Inc-Detailed Product Pipeline
| Sep 2009 |
£455 |
Isolagen Inc-Detailed Product Pipeline
| Sep 2009 |
£455 |
Infinity Pharmaceuticals Inc-Detailed Product Pipeline
| Sep 2009 |
£455 |
Immunosyn Corporation-Detailed Product Pipeline
| Sep 2009 |
£455 |
Incyte Corporation-Detailed Product Pipeline
| Sep 2009 |
£455 |
Introgen Therapeutics Inc-Detailed Product Pipeline
| Sep 2009 |
£455 |
Inhibitex Inc-Detailed Product Pipeline
| Sep 2009 |
£455 |
Imarx Therapeutics, Inc.-Detailed Product Pipeline
| Sep 2009 |
£455 |
Immunomedics Inc-Detailed Product Pipeline
| Sep 2009 |
£455 |
Intellect Neurosciences, Inc.-Detailed Product Pipeline
| Sep 2009 |
£455 |
Immtech Pharmaceuticals Inc-Detailed Product Pipeline
| Sep 2009 |
£455 |
ImmunoGen Inc-Detailed Product Pipeline
| Sep 2009 |
£455 |
ImmunoCellular Therapeutics, Ltd.-Detailed Product Pipeline
| Sep 2009 |
£455 |
Hi-Tech Pharmacal Co Inc-Detailed Product Pipeline
| Sep 2009 |
£455 |
Human Genome Sciences Inc-Detailed Product Pipeline
| Sep 2009 |
£455 |
Forticell Bioscience, Inc.-Detailed Product Pipeline
| Sep 2009 |
£455 |
Exelixis Inc-Detailed Product Pipeline
| Sep 2009 |
£455 |
Amicus Therapeutics, Inc.-Detailed Product Pipeline
| Sep 2009 |
£455 |
Forest Laboratories Inc-Detailed Product Pipeline
| Sep 2009 |
£455 |
GammaCan International Inc-Detailed Product Pipeline
| Sep 2009 |
£455 |
Flamel Technologies SA ADS-Detailed Product Pipeline
| Sep 2009 |
£455 |
Eugene Science Inc-Detailed Product Pipeline
| Sep 2009 |
£455 |
Endo Pharmaceuticals Holdings Inc-Detailed Product Pipeline
| Sep 2009 |
£455 |
Enzo Biochem Inc-Detailed Product Pipeline
| Sep 2009 |
£455 |
EntreMed Inc-Detailed Product Pipeline
| Sep 2009 |
£455 |
Enzon Pharmaceuticals Inc-Detailed Product Pipeline
| Sep 2009 |
£455 |
Genzyme Corporation-Detailed Product Pipeline
| Sep 2009 |
£455 |
Geron Corporation-Detailed Product Pipeline
| Sep 2009 |
£455 |
Cytomedix Inc-Detailed Product Pipeline
| Sep 2009 |
£455 |
Halozyme Therapeutics Inc-Detailed Product Pipeline
| Sep 2009 |
£455 |
Hollis-Eden Pharmaceuticals Inc-Detailed Product Pipeline
| Sep 2009 |
£455 |
Hemispherx Biopharma Inc-Detailed Product Pipeline
| Sep 2009 |
£455 |
GTC Biotherapeutics Inc-Detailed Product Pipeline
| Sep 2009 |
£455 |
GeoVax Labs Inc-Detailed Product Pipeline
| Sep 2009 |
£455 |
Gilead Sciences Inc-Detailed Product Pipeline
| Sep 2009 |
£455 |
Generex Biotechnology Corporation-Detailed Product Pipeline
| Sep 2009 |
£455 |
Genta Incorporated-Detailed Product Pipeline
| Sep 2009 |
£455 |
GeoPharma Inc-Detailed Product Pipeline
| Sep 2009 |
£455 |
Insmed Incorporated-Detailed Product Pipeline
| Sep 2009 |
£455 |
Isis Pharmaceuticals Inc-Detailed Product Pipeline
| Sep 2009 |
£455 |
MicroIslet, Inc.-Detailed Product Pipeline
| Sep 2009 |
£460 |
Manhattan Pharmaceuticals Inc.-Detailed Product Pipeline
| Sep 2009 |
£460 |
Micromet Inc-Detailed Product Pipeline
| Sep 2009 |
£460 |
Molecular Insight Pharmaceuticals, Inc.-Detailed Product Pipeline
| Sep 2009 |
£460 |
MediciNova Inc-Detailed Product Pipeline
| Sep 2009 |
£460 |
Medarex Inc-Detailed Product Pipeline
| Sep 2009 |
£460 |
Medivation Inc-Detailed Product Pipeline
| Sep 2009 |
£460 |
Metabasis Therapeutics Inc-Detailed Product Pipeline
| Sep 2009 |
£460 |
MultiCell Technologies Inc-Detailed Product Pipeline
| Sep 2009 |
£460 |
The Medicines Company-Detailed Product Pipeline
| Sep 2009 |
£460 |
Medistem, Inc.-Detailed Product Pipeline
| Sep 2009 |
£460 |
MannKind Corp-Detailed Product Pipeline
| Sep 2009 |
£460 |
Momenta Pharmaceuticals Inc-Detailed Product Pipeline
| Sep 2009 |
£460 |
Myriad Genetics Inc-Detailed Product Pipeline
| Sep 2009 |
£460 |
Mylan, Inc.-Detailed Product Pipeline
| Sep 2009 |
£460 |
North American Scientific Inc-Detailed Product Pipeline
| Sep 2009 |
£460 |
Nabi Biopharmaceuticals-Detailed Product Pipeline
| Sep 2009 |
£460 |
Mannatech Inc-Detailed Product Pipeline
| Sep 2009 |
£460 |
Matrixx Initiatives Inc-Detailed Product Pipeline
| Sep 2009 |
£460 |
Merck & Co Inc-Detailed Product Pipeline
| Sep 2009 |
£460 |
MDRNA, Inc.-Detailed Product Pipeline
| Sep 2009 |
£460 |
Medicis Pharmaceutical Corp-Detailed Product Pipeline
| Sep 2009 |
£460 |
Marshall Edwards Inc-Detailed Product Pipeline
| Sep 2009 |
£460 |
MiddleBrook Pharmaceuticals, Inc.-Detailed Product Pipeline
| Sep 2009 |
£460 |
Maxygen Inc-Detailed Product Pipeline
| Sep 2009 |
£460 |
Jazz Pharmaceuticals, Inc.-Detailed Product Pipeline
| Sep 2009 |
£455 |
Javelin Pharmaceuticals Inc-Detailed Product Pipeline
| Sep 2009 |
£455 |
Keryx Biopharmaceuticals Inc-Detailed Product Pipeline
| Sep 2009 |
£455 |
Johnson & Johnson-Detailed Product Pipeline
| Sep 2009 |
£455 |
King Pharmaceuticals Inc-Detailed Product Pipeline
| Sep 2009 |
£455 |
InterMune Inc-Detailed Product Pipeline
| Sep 2009 |
£455 |
InSite Vision Incorporated-Detailed Product Pipeline
| Sep 2009 |
£455 |
IR Biosciences Holdings Inc-Detailed Product Pipeline
| Sep 2009 |
£455 |
Inspire Pharmaceuticals Inc-Detailed Product Pipeline
| Sep 2009 |
£455 |
ISTA Pharmaceuticals Inc-Detailed Product Pipeline
| Sep 2009 |
£455 |
IsoRay Inc-Detailed Product Pipeline
| Sep 2009 |
£455 |
Lannett Co Inc-Detailed Product Pipeline
| Sep 2009 |
£455 |
Lescarden Inc-Detailed Product Pipeline
| Sep 2009 |
£455 |
Lpath Inc-Detailed Product Pipeline
| Sep 2009 |
£455 |
Lotus Pharmaceuticals, Inc.-Detailed Product Pipeline
| Sep 2009 |
£455 |
Lexicon Pharmaceuticals, Inc-Detailed Product Pipeline
| Sep 2009 |
£455 |
MAP Pharmaceuticals, Inc.-Detailed Product Pipeline
| Sep 2009 |
£455 |
Eli Lilly & Co-Detailed Product Pipeline
| Sep 2009 |
£455 |
Lee Pharmaceuticals-Detailed Product Pipeline
| Sep 2009 |
£455 |
Ligand Pharmaceuticals Inc-Detailed Product Pipeline
| Sep 2009 |
£455 |
Lixte Biotechnology Holdings, Inc.-Detailed Product Pipeline
| Sep 2009 |
£455 |
Lipid Sciences Inc-Detailed Product Pipeline
| Sep 2009 |
£455 |
La Jolla Pharmaceutical Co-Detailed Product Pipeline
| Sep 2009 |
£455 |
NatureWell Inc-Detailed Product Pipeline
| Sep 2009 |
£460 |